Tenet Healthcare Corporation (THC) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

BULLISH

Tenet Healthcare’s most recent insider activity—director Nadja West selling 5 % of her direct holdings for roughly $298 k—came just after the company posted a 39 % year‑to‑date return, suggesting a short‑term confidence dip that could temper momentum in the next few trading days. The sale is unlikely to alter the long‑term stake, but it signals that some insiders are taking liquidity, a cue investors should weigh against the company’s upcoming earnings. A day earlier, THC’s price broke out above key resistance levels with volume and a moving‑average crossover that technical analysts flag as high‑probability, implying a potential short‑term rally if the breakout holds. The breakout aligns with a broader market rally, so THC could ride that wave for the next week, but traders should watch the next resistance zone near $X for reversal signals. On the fundamentals side, Zacks has placed THC on its Rank #1 Strong‑Buy list, citing a PEG of 0.81 and recent earnings revisions that reinforce a bullish outlook, which may attract value‑oriented traders in the coming days. The company’s $2.0 b refinancing and revenue‑cycle restructuring, highlighted in recent reports, could improve earnings quality and reduce interest costs, a development that may support the stock’s valuation if the debt terms are favorable. Demand for THC’s services remains robust due to an aging population and higher‑acuity procedures, but margin pressure from rising drug, supply, and labor costs could temper earnings growth, a risk that investors should monitor in the next earnings cycle. Finally, the combination of insider selling, a bullish technical setup, and a strong analyst consensus creates a mixed outlook: the stock may see short‑term upside if the breakout sustains, yet any sign of margin erosion or a reversal at the next resistance could quickly shift sentiment. Watch for the next earnings release and any updates to the refinancing terms, as these will be the key catalysts for the next 1–10 trading days.

THC|Analyst Targets

LOW TARGET

$260 -0.2%

2 analysts

MEAN TARGET

$286 +9.6%

12 analysts

HIGH TARGET

$315 +20.9%

15 analysts

PRICE RANGE

$260.00 - $315.00

SB / B / H / S / SS

6/17/4/1/1

DAILYIQ EST.

$291.39 (+11.8%)

THC|Company Info

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NYQ

Country

United States

Website

tenethealth.com

Symbol

THC

Description

Tenet Healthcare Corporation is a U.S.-based healthcare services provider operating through two primary segments: Hospital Operations and Services, and Ambulatory Care. The company's core value proposition lies in its comprehensive network of acute care hospitals, offering a wide array of services including surgery, radiology, and specialized treatments for various conditions. These hospitals also provide intensive care, specialized surgical procedures, and tertiary care services. Furthermore, Tenet expands its reach through ambulatory surgery centers, urgent care facilities, and imaging centers, providing convenient access to outpatient care. Founded in 1967, the company's diversified service offerings and extensive physical footprint are key elements of its competitive positioning within the healthcare landscape.

THC|Insider Trading

Bought (1Y)

0 shares

Sold (1Y)

194,837 shares

$51.5M

KERREY J ROBERT-

Sell2,502 shares2026-09-14

KERREY J ROBERT-

Sell4,025 shares2026-09-14

KERREY J ROBERT-

Sell5,483 shares2026-09-14

MARK RICHARD J-

Sell10,000 shares2026-09-10

West Nadja-

Sell1,152 shares2026-09-02

THC|Fundamentals

Neutral / mixed

Verdict: Neutral

✓Revenue growing year over year

✓Positive net margin

✓Positive operating cash flow

Net Margin

3.6%

Revenue CAGR

5.5%

Current Ratio

1.76x

Debt / Equity

3.10x

Return on Equity

18.2%

THC|Earnings Snapshot

Earnings Summary

Tenet Healthcare Corporation operates a diversified network of acute care hospitals and ambulatory surgery centers, providing a broad spectrum of medical services including surgery, radiology, and specialized treatments, positioning it as a key player in the medical care facilities sector. In Q4 2024, Tenet reported EPS of $3.44 versus an estimate of $2.83, while revenue reached $5.072 billion, a modest increase from prior periods; in Q4 2025 the company again beat expectations with EPS of $4.70 against an estimate of $4.09 and revenue of $5.527 billion nearly flat against the $5.527 billion estimate, indicating a steady revenue trajectory and consistent earnings outperformance. The two most recent quarters show a pattern of EPS growth and revenue stability, with the company beating analyst estimates in both periods and maintaining a 7 % revenue growth in Q2 2026, though EPS data for Q2 and Q3 2026 are pending. Historically, Tenet has demonstrated year‑over‑year revenue growth while occasionally missing on EPS guidance, yet it has consistently delivered earnings above consensus, underscoring a resilient profitability profile amid a competitive healthcare landscape. Recent news highlights Tenet’s participation in the Wells Fargo 21st Annual Healthcare Conference, where leadership reiterated operational efficiencies without altering guidance, and a significant debt refinancing that upsized its private senior notes to $2 billion, reducing short‑term leverage and extending the debt maturity profile; these developments reinforce the company’s focus on balance‑sheet strength and operational discipline. Investors should watch for the closing of the notes on September 22, 2026, any updates to guidance or cost‑control initiatives presented at the conference, and the release of Q2 and Q3 2026 earnings to assess whether the company sustains its EPS beat and revenue growth trajectory in the coming quarters.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$4.64	-	-
Q4'25	$4.09	$4.70	+14.8%
Q4'24	$2.83	$3.44	+21.5%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$5.5B	-	-
Q4'25	$5.5B	$5.5B	+0.0%
Q4'24	-	$5.1B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

THC|Monthly Returns

Market Data

THC Stock Snapshot

HOLD55/100

$260.61−$1.38 (0.5%)

Market cap: 21.10B
P/E ratio: 9.4
Day range: $258.02 – $263.58
News sentiment: 63/100 · Bullish
Analyst target: $285.57 (+9.6%)
Consensus: Buy · 29 analysts

52-week range+65.4% off low · -8.4% from high

$157.58$284.60

Price $260.61 DailyIQ Est. $291.39

Tenet Healthcare Corporation is consolidating: price is in the upper part of its 52-week range without a decisive push either way. The stock is liquid enough that positioning changes get absorbed without distorting the trend.

Reverse DCF

What growth is priced into THC?

CHEAP

At today's price, Tenet Healthcare Corporation needs to grow free cash flow about -8.0% a year for the next 10 years to justify its valuation at a 7.44% cost of capital. Over its actual history it has compounded free cash flow at 30.0% a year, so the market is asking for 38.0 percentage points below its own delivered rate. On that basis THC looks priced below what its own growth record supports.

Implied FCF growth: -8.0%
Historical FCF CAGR: 30.0%
Growth gap: -38.0 pts
Verdict: CHEAP
Discount rate (WACC): 7.44%
Beta: 0.77

Behaviour On Record

What THC's own history says about today's numbers

Realized volatility (21d): 27.8% 11th pct
Below its peak: -6.7%
vs 200-day average: +23.5%
Up days (1y): 50%

Tenet Healthcare Corporation is currently running 27.8% annualised volatility over the last 21 sessions. Measured against THC's own 13 years of daily returns rather than a market-wide average, that is the 11th percentile — unusually subdued by its own history, against a typical reading of 43.6%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

THC is trading -6.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -46.0%, and the deepest was -71.7% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +23.5% from its 200-day moving average. Against every other day in its history, that gap ranks at the 72nd percentile — a somewhat wider gap than its own norm. Over the past year THC closed higher on 50% of sessions, and it is currently 1 session into a falling streak.

On September specifically: over 13 years of records, THC finished the month higher 3 of 13 times, with a median return of -8.5% and an average of -6.5%. Its strongest month historically has been July at +10.9% on average, its weakest September at -6.5%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: THC has opened more than 2% away from the prior close in 288 of 3,267 sessions (8.8% of the time), with the largest gaps running +11.0% and -12.7%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

All figures computed from 3,268 daily closes between 2013-09-23 and 2026-09-21, split-adjusted, recomputed daily. Percentiles are against THC's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of THC's sector?

Tenet Healthcare Corporation sits in the Health Care sector, currently ranked 5th of 11 GICS sectors by relative-strength rotation score (improving).

Sector rank: #5 of 11
Sector state: Improving
Sector rotation score: 80

Options Market

What is the options market pricing for THC?

CallsPuts

For Tenet Healthcare Corporation's nearest expiry (2026-10-16, 25 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 1.84), with at-the-money implied volatility around 43.2%. The options market is pricing roughly a ±10.4% move by that expiry — a range of about $233.54–$287.68.

Put/call ratio (2026-10-16): 1.84
ATM implied volatility: 43.2%
Total open interest: 3,229
Expected move by 2026-10-16: ±10.4% ($233.54–$287.68)

Analyst Rating Changes

Are analysts turning bullish or bearish on THC?

Leerink Partners most recently reiterated its rating on Tenet Healthcare Corporation to Outperform on Sep 18, 2026 with a price target of $309. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action: Leerink Partners — Outperform
90-day upgrades: 0
90-day downgrades: 0
Net rating momentum: 0

Date	Firm	Action	Rating	Price target
Sep 18, 2026	Leerink Partners	Maintained	Outperform	$309
Aug 3, 2026	Wells Fargo	Maintained	Overweight	$231 → $281
Jul 28, 2026	Truist Securities	Maintained	Buy	$270 → $290
Jul 28, 2026	Baird	Maintained	Neutral	$210 → $280
Jul 28, 2026	Guggenheim	Maintained	Buy	$242 → $283
Jul 27, 2026	UBS	Maintained	Buy	$288 → $308
Jul 27, 2026	TD Cowen	Maintained	Buy	$233 → $263
Jul 27, 2026	Morgan Stanley	Maintained	Overweight	$254 → $274
Jul 27, 2026	RBC Capital	Maintained	Outperform	$236 → $283
Jul 24, 2026	Barclays	Maintained	Overweight	$240 → $271
Jul 20, 2026	Guggenheim	Maintained	Buy	$252 → $242
Jul 13, 2026	Wells Fargo	Maintained	Overweight	$213 → $231

THC Competitive Positioning

Tenet Healthcare Corporation (THC) is tracked alongside these names in Medical Care Facilities on DailyIQ — ranked by market cap, with today's move alongside.

THCyou're hereTenet Healthcare Corporation$21.1B-0.53%
HCAHCA Healthcare, Inc.$92.6B+0.54%
DVADaVita Inc.$11.7B-0.17%
UHSUniversal Health Services, Inc.$10.4B-1.03%

Held by These ETFs

THC is a top holding in these ETFs tracked on DailyIQ — bar length shows portfolio weight.

News Sentiment Analysis

Sentiment gathered from recent headlines

63/100

Strong NegativeNeutralStrong Positive

MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Tenet Healthcare (THC) has been identified by Zacks as a top‑ranked stock likely to deliver an earnings beat in the upcoming quarter. The analysis highlights the company’s solid financial fundamentals and recent initiatives that support a positive earnings surprise. A beat would reinforce investor confidence and could lift the stock’s valuation relative to peers. Traders should monitor the actual earnings release for any guidance updates or commentary on growth prospects.

What did this article say?

Tenet Healthcare director Nadja West sold 1,152 shares, roughly 5% of her direct holdings, generating about $298,000 in proceeds. The sale occurred at a price of $258.80, shortly after the company posted a 39% one‑year total return. While the transaction represents a modest portion of her stake, it may signal short‑term confidence concerns for investors. The remaining 23,653 shares are still valued at over $6 million, indicating continued long‑term exposure. Market watchers should assess whether this sale reflects broader insider sentiment or is an isolated liquidity move.

What did this article say?

Tenet Healthcare Corp (THC) has entered a bullish technical phase, with price action forming a clear breakout pattern above key resistance levels. The stock’s recent consolidation has been followed by a sharp move upward, suggesting renewed buying interest. Technical analysts highlight the breakout’s high probability, citing volume support and a favorable moving‑average crossover. Traders should monitor the next resistance zone near $X and watch for any reversal signals that could signal a pullback. The breakout also aligns with a broader market rally, potentially amplifying THC’s upside potential.

What did this article say?

Tenet Healthcare (THC), Acadia Healthcare, and Community Health Systems are highlighted as benefiting from a favorable demand environment driven by an aging population and higher acuity care. While margin expansion faces headwinds from rising drug, supply, and labor costs, the companies are tightening cost discipline and investing in AI and strategic M&A to protect profitability. The article suggests a mild tailwind for THC as it navigates these pressures.

What did this article say?

Tenet Healthcare’s stock has delivered a 281.9% return over the past three years, raising questions about whether the current price reflects its earnings potential. Recent developments, including Conifer layoffs and a $2.0 b refinancing, indicate management is reshaping the revenue cycle and debt structure, which could influence future earnings quality and interest costs. The article presents a cautiously optimistic view of THC’s valuation relative to earnings.

What did this article say?

Tenet Healthcare (THC) is benefiting from a favorable demand environment driven by an aging population and higher‑acuity procedures, while the company is tightening costs through AI investments and strategic M&A. Rising drug, supply and labor costs are offset by improved operational efficiency, but payer mix remains a concern. The company’s focus on cost discipline and scale expansion positions it to protect margins in a competitive market.

What did this article say?

Zacks analysts highlight Tenet Healthcare (THC) as a top value pick, citing its Zacks Rank #1 (Strong Buy) and A‑grade Value score. The company’s PEG ratio of 0.81 suggests earnings growth outpacing valuation, reinforcing its undervaluation thesis. Analysts note that THC’s robust earnings estimates and positive revision trend support a bullish outlook. The article frames THC as a compelling opportunity for value investors seeking upside potential.

What did this article say?

The Zacks Rank #1 (Strong Buy) list for September 16, 2026 now includes THC alongside PARR and KMT, signaling renewed value‑sector interest. The inclusion reflects THC’s attractive valuation metrics and recent earnings momentum, positioning it as a compelling buy for value‑oriented investors. Analysts note that THC’s price‑to‑earnings ratio remains well below industry peers, suggesting potential upside if the company maintains its earnings trajectory. The ranking may influence short‑term trading activity as investors seek to capitalize on the perceived undervaluation. Market participants should monitor THC’s upcoming earnings release and any guidance updates that could confirm or challenge the value thesis.

What did this article say?

Tenet Healthcare (THC) ended the latest session at $260.85, a 1.38% decline that outpaced the S&P 500’s 0.45% loss. The company’s projected EPS of $4.59 and revenue of $5.47 billion signal a 24% and 3% year‑over‑year rise, respectively. Investors are awaiting the earnings announcement to assess the strength of the positive guidance.

What did this article say?

Tenet Healthcare (THC) shares fell 1.3% after a board member, Richard Mark, sold 10,000 shares for roughly $2.6 million. The sale was disclosed in a regulatory filing dated September 10. Mark remains a significant shareholder, holding 25,121 shares post‑sale. The transaction signals a modest negative sentiment but is unlikely to materially alter the company’s outlook.

Technical Analysis

Real-time indicators across multiple timeframes

NEUTRAL

Technical indicators reflect the latest computed signal mix for this timeframe.

Unlock full technicals

Create a free account to access more indicators and deeper timeframe data.

Institutional & Hedge Fund Ownership

25 tracked managers · $7.99B combined position · 16 adding, 8 trimming, 1 unchanged (latest 13F filings)

Manager	Trend	Shares Held	% of Co.	Position Value	Filed
Vanguard Group Inc	▼ Sell	8,856,018	10.96%	$1.76B	2026-01-29
BlackRock, Inc.	▲ Buy	8,743,005	10.82%	$1.64B	2026-08-07
FMR LLC (Fidelity)	▼ Sell	3,994,545	4.94%	$747.30M	2026-08-13
Lone Pine Capital LLC	▲ Buy	2,258,717	2.79%	$426.24M	2026-05-15
Glenview Capital Management, LLC	▲ Buy	2,235,666	2.77%	$418.25M	2026-08-14
Citadel Advisors LLC	• Hold	2,107,596	2.61%	$394.29M	2026-09-02
Geode Capital Management, LLC	▼ Sell	1,884,982	2.33%	$352.72M	2026-08-12
Invesco Ltd.	▼ Sell	1,416,948	1.75%	$265.08M	2026-08-14
Norges Bank	▼ Sell	1,214,240	1.50%	$227.16M	2026-08-12
AQR Capital Management LLC	▼ Sell	1,067,556	1.32%	$198.27M	2026-08-14
AllianceBernstein L.P.	▲ Buy	910,270	1.13%	$171.78M	2026-08-14
Pentwater Capital Management LP	▲ Buy	885,000	1.09%	$165.57M	2026-08-14
Bank of America Corp	▲ Buy	854,858	1.06%	$159.93M	2026-08-14
Morgan Stanley	▲ Buy	831,612	1.03%	$155.58M	2026-08-13
Eminence Capital, LP	▲ Buy	790,302	0.98%	$149.14M	2026-05-15
Northern Trust Corp	▼ Sell	781,265	0.97%	$146.16M	2026-08-13
Goldman Sachs Group Inc	▲ Buy	478,017	0.59%	$89.43M	2026-08-14
Millennium Management LLC	▲ Buy	477,287	0.59%	$89.29M	2026-08-14
Farallon Capital Management LLC	▲ Buy	452,153	0.56%	$85.33M	2026-05-15
Susquehanna International Group, LLP	▲ Buy	436,730	0.54%	$81.70M	2026-08-14
JPMorgan Chase & Co	▲ Buy	414,661	0.51%	$78.36M	2026-08-12
Citigroup Inc	▲ Buy	338,023	0.42%	$63.24M	2026-08-03
Wells Fargo & Company	▲ Buy	257,162	0.32%	$48.11M	2026-08-14
Adage Capital Partners GP, L.L.C.	▲ Buy	238,848	0.30%	$44.68M	2026-08-14
Wellington Management Group LLP	▼ Sell	207,419	0.26%	$38.80M	2026-08-14

Q2 2026 flow:2.49M sh bought ($466.30M)6.75M sh sold ($1.26B)net -4.26M sh (−$796.05M)

Congressional Trading Activity

7 disclosed trades · ~$105.0K est. traded value · 3 buys, 4 sells

Member	Chamber	State	Type	Amount	Traded	Filed
Jonathan Jackson	House	IL01	▼ Sell	$15K - $50K	2026-04-20	2026-05-27
Jonathan Jackson	House	IL01	▼ Sell	$1K - $15K	2026-04-15	2026-05-27
Jonathan Jackson	House	IL01	▼ Sell	$1K - $15K	2026-02-11	2026-03-12
Jonathan Jackson	House	IL01	▲ Buy	$15K - $50K	2025-12-10	2026-01-08
Jonathan Jackson	House	IL01	▲ Buy	$1K - $15K	2025-09-03	2025-10-15
Lisa McClain	House	MI09	▼ Sell	$1K - $15K	2025-08-04	2025-09-12
Lisa McClain	House	MI09	▲ Buy	$1K - $15K	2025-06-11	2025-08-13

THC·Tenet Healthcare Corporation

EPS

Revenue

THC Stock Snapshot

What growth is priced into THC?

What THC's own history says about today's numbers

Is money rotating into or out of THC's sector?

What is the options market pricing for THC?

Are analysts turning bullish or bearish on THC?

THC Competitive Positioning

Held by These ETFs

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

Recently Viewed

Portfolio

Email Alerts

Portfolio News

Economic Events

Earnings Events

Economic News

THC·Tenet Healthcare Corporation

EPS

Revenue

THC Stock Snapshot

What growth is priced into THC?

What THC's own history says about today's numbers

Is money rotating into or out of THC's sector?

What is the options market pricing for THC?

Are analysts turning bullish or bearish on THC?

THC Competitive Positioning

Held by These ETFs

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

Discover More

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

Discover More

Recently Viewed

Portfolio

Email Alerts

Portfolio News

Economic Events

Earnings Events

Economic News